SCHEMBL15445138

SCHEMBL15445138

COC(=O)C(=[N+]=[N-])c1ccc(C)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.52
ALDH1A1 P00352 7/20 0.49
MAPT P10636 2/20 0.49
KDM4E B2RXH2 1/20 0.49
GAA P10253 1/20 0.44
LMNA P02545 2/20 0.43
CES2 O00748 2/20 0.43
CES1 P23141 2/20 0.43
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
RAB9A P51151 6/20 0.40
NPC1 O15118 5/20 0.40
MMP13 P45452 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
PKM P14618 2/20 0.39
HTT P42858 2/20 0.39
ATM Q13315 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28366619 0.85 CA1 (0.52) TDP1ALDH1A1MAPTKDM4ERAB9A
SCHEMBL14638953 0.84 TPMT (0.41) TDP1ALDH1A1MAPTKDM4E
SCHEMBL1702960 0.84 MEN1 (0.44) TDP1ALDH1A1MAPTLMNACES2
SCHEMBL27154482 0.84 RAB9A (0.44) ALDH1A1MAPTKDM4EGAALMNA
SCHEMBL14638933 0.84 CA1 (0.53) MAPTLMNACES2CES1HDAC1
SCHEMBL926435 0.84 HPGD (0.44) ALDH1A1MAPTKDM4ELMNACES2
SCHEMBL545737 0.83 TSHR (0.50) TDP1ALDH1A1MAPTKDM4ELMNA
SCHEMBL28321122 0.82 SMN1; SMN2 (0.45) TDP1ALDH1A1MAPTGAALMNA
SCHEMBL28470289 0.81 ALDH1A1 (0.41) TDP1ALDH1A1MAPTKDM4EGAA
SCHEMBL13735831 0.81 SMN1; SMN2 (0.47) ALDH1A1MAPTLMNAHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110734441-B 3, 3' -pyrrolidine indole spiro-compound and preparation method and application thereof 广州大学 2020-09-04 CN claimed
CN-110734441-A 3, 3' -pyrrolidine indole spiro-compound and preparation method and application thereof 广州大学 2020-01-31 CN claimed
CN-104109108-A Alpha-quaternary carbon contained alpha,beta-diamino acid derivatives, and cocatalytic preparation method and application thereof UNIV EAST CHINA NORMAL 2014-10-22 CN claimed
CN-104072449-A Full-substituted tetrahydrofuran derivative as well as preparation method and application thereof UNIV EAST CHINA NORMAL 2014-10-01 CN claimed
CN-104059049-A Benzo dioxy heterocyclic derivatives with optical activity and preparation method and application thereof UNIV EAST CHINA NORMAL 2014-09-24 CN claimed
CN-104058998-A Alpha-amino and delta-hydroxyl adipic acid derivatives and preparation method and application thereof UNIV EAST CHINA NORMAL 2014-09-24 CN claimed
CN-103242209-A Preparation method of alpha-amido, delta-hydroxyl adipic acid derivatives UNIV EAST CHINA NORMAL 2013-08-14 CN claimed
CN-103204833-A Preparation method of fully-substituted tetrahydrofuran derivative UNIV EAST CHINA NORMAL 2013-07-17 CN claimed
CN-103204786-A Co-catalyzing preparation method of alpha, betal-diamino acid derivative of alpha-quaternary carbon UNIV EAST CHINA NORMAL 2013-07-17 CN claimed
CN-117777127-A Chiral tetrahydro-beta-carboline derivative and preparation method and application thereof 中山大学 2024-03-29 CN disclosed
CN-116675658-A Process for preparing gamma-vinylidene-butenoic acid lactones and/or benzofulvenes 中北大学 2023-09-01 CN disclosed
CN-112898213-B Polysubstituted 1, 3-diene supported ring compound and application thereof 中国科学院上海药物研究所 2022-11-04 CN disclosed
CN-112898213-A Polysubstituted 1, 3-diene supported ring compound and application thereof 中国科学院上海药物研究所 2021-06-04 CN disclosed
CN-108658812-B Alpha-alkoxy-alpha-nitrogen oxyacetate derivative and synthesis method and application thereof 华东师范大学 2020-12-22 CN disclosed
US-20140249199-A1 TAK1 KINASE INHIBITORS, COMPOSITIONS, AND USED RELATED THERETO HEALTH RESEARCH, INC. (US) 2014-09-04 US disclosed
EP-2689847-A1 Methods for catalytic alkylation of nucleic acids Universität Basel (CH) 2014-01-29 EP disclosed
CN-103204833-A Preparation method of fully-substituted tetrahydrofuran derivative UNIV EAST CHINA NORMAL 2013-07-17 CN disclosed
CN-103204786-A Co-catalyzing preparation method of alpha, betal-diamino acid derivative of alpha-quaternary carbon UNIV EAST CHINA NORMAL 2013-07-17 CN disclosed
CN-102070510-B 3-hydroxyindole derivatives and synthesis method and use thereof UNIV EAST CHINA NORMAL 2012-10-31 CN disclosed
CN-102070510-A 3-hydroxyindole derivatives and synthesis method and use thereof UNIV EAST CHINA NORMAL 2011-05-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140249199-A1 TAK1 KINASE INHIBITORS, COMPOSITIONS, AND USED RELATED THERETO TAB1, MAP3K1, MAP3K6 TDP1 1139/4885ALDH1A1 3574/4885MAPT 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.